Massive Bio helps pre-screen patients for clinical trials, streamlining the trial enrollment process and reducing clinical staff time.

Myelofibrosis Trial
Myelofibrosis Trial

A phase 3 randomized, double-blind, placebo-controlled study in participants with Myelofibrosis.

  • Phase 3 Study
  • Sex: Male, Female
  • Age 18+
Prostate Cancer Trial
Prostate Cancer Trial

A phase 3 randomized, double-blind study in men with metastatic castration-resistant prostate cancer.

  • Phase 3 Study
  • Sex: Male
  • Age 18+
Stage IV Pancreatic Cancer Trial
Stage IV Pancreatic Cancer Trial

A phase 3, randomized clinical trial for patients with stage IV adenocarcinoma of the pancreas with no prior treatment for metastatic disease.

  • Phase 3 Study
  • Sex: Male, Female
  • Age 18+
  • Randomized
Breast Cancer Trial
Breast Cancer Trial

A phase 2, non-randomized clinical trial for patients with metastatic breast cancers harboring FGFR amplifications.

  • Phase 2 Study
  • Sex: Male, Female
  • Age 18+
  • Non-Randomized
Follicular Lymphoma Trial
Follicular Lymphoma Trial

A phase 2, non-randomized clinical trial for treatment with an Anti-CD20 and Anti-CD3 Bispecific Antibody of patients with B-Cell Non-Hodgkin Lymphoma, grades to 3b who have received at least 2 lines of prior systemic therapy.

  • Phase 2 Study
  • Sex: Male, Female
  • Age 18+
  • Non-randomized
Cervical Cancer Trial
Cervical Cancer Trial

A phase 2, randomized clinical trial for patients with squamous-cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix, and metastatic, locally advanced, and/or unresectable disease.

  • Phase 2 Study
  • Sex: Male, Female
  • Age 18+
  • Randomized
Non-Small Cell Lung Cancer Trial
Non-Small Cell Lung Cancer Trial

A first-in-human/phase 1/2 clinical trial for patients with non-small cell lung cancer with MET alteration.

  • Phase 1/2, FIH Study
  • Sex: Male, Female
  • Age 18+
  • Randomized

Massive Bio’s SYNERGY-AI database combines artificial intelligence, genomic biomarkers, and multi-variate analysis to accelerate clinical trial matching and promote access to promising cancer therapies. We then help facilitate enrollment into the study by providing support during the transition.


    Provider Referral

    Please provide your patient’s contact information, and a representative will contact them soon.

    Patient has been informed that Massive Bio will be contacting them. YesNo

    By submitting this form, you agree to the Privacy Policy and Terms & Conditions.

    For questions, please contact us at support@massivebio.com or 844-627-7246

    Looking for a different trial?

    Take advantage of our Clinical Trial Matching Service. Massive Bio is 4x more successful in finding cancer clinical trial matches for patients than any other service provider.